The DOI matches its Crossref record; 141 of the 142 references it cites were found in a registry or an index.
Mortality in COPD: role of comorbidities
Open accessAbstract
Chronic obstructive pulmonary disease (COPD) represents an increasing burden throughout the world. COPD-related mortality is probably underestimated because of the difficulties associated with identifying the precise cause of death. Respiratory failure is considered the major cause of death in advanced COPD. Comorbidities such as cardiovascular disease and lung cancer are also major causes and, in mild-to-moderate COPD, are the leading causes of mortality. The links between COPD and these conditions are not fully understood. However, a link through the inflammation pathway has been suggested, as persistent low-grade pulmonary and systemic inflammation, both known risk factors for cardiovascular disease and cancer, are present in COPD independent of cigarette smoking. Lung-specific measurements, such as forced expiratory volume in one second (FEV(1)), predict mortality in COPD and in the general population. However, composite tools, such as health-status measurements (e.g. St George's Respiratory Questionnaire) and the BODE index, which incorporates Body mass index, lung function (airflow Obstruction), Dyspnoea and Exercise capacity, predict mortality better than FEV(1) alone. These multidimensional tools may be more valuable because, unlike predictive approaches based on single parameters, they can reflect the range of comorbidities and the complexity of underlying mechanisms associated with COPD. The current paper reviews the role of comorbidities in chronic obstructive pulmonary disease mortality, the putative underlying pathogenic link between chronic obstructive pulmonary disease and comorbid conditions (i.e. inflammation), and the tools used to predict chronic obstructive pulmonary disease mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“as well as multiple co-morbidities, including cardiovascular, immune, musculoskeletal and affective disorders (Sin et al., 2006; Fabbri et al., 2008).”
From Effectiveness of a Novel Qigong Meditative Movement Practice for Impaired Health in Flight Attendants Exposed to Second-Hand Cigarette Smoke (2017) · cites this paper as Sin et al., 2006
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Murray, C. J. L., & López, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07492-2 · Cited by 7,007
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880
Celli, B. R., MacNee, W., Agustí, A. G. N., Anzueto, A. R., Berg, B., Buist, A. S., Calverley, P. M., Chavannes, N. H., Dillard, T. A., Fahy, B. F., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,405
Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
Hogg, J. C., Chu, F. S. F., Utokaparch, S., Woods, R. R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032158 · Cited by 3,828
Research works printed but not linked: 11
- 1997, Monaldi Arch Chest Dis, 52, 43
- 1998, Monaldi Arch Chest Dis, 53, 324
- 1999, Eur Respir J, 14, 387s
- 10.1001/jama.1994.03520190043033 · DOI
- 2000, J Am Geriatr Soc, 48, S91
- European Respiratory Society, European Lung Foundation. Loddenkemper R, Gibson GJ, Sibille Y, eds. Lung Health in Europe Facts and Figures. Sheffield, ERSJ, 2003; pp. 34–43
- 2004, Chest, 125, 134S
- 1998, Int J Mol Med, 2, 715
- 2001, Chest, 119, 1294
- 1995, Oncogene, 11, 999
- 1978, Scand J Respir Dis, 59, 154
Cited by
Sorted by citations
Items 201–300 of 999
Margrétardóttir, Ó. B., Thorleifsson, S. J., Guðmundsson, G., Ólafsson, Í., Benediktsdóttir, B., Janson, C., Buist, A. S., & Gíslason, Þ. (2009) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550903049157 · Cited by 57
Wang, Y., Kuang, X., Yin, Y., Han, N., Chang, L., Wang, H., Hou, Y., Li, H., Li, Z., Liu, Y., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112367 · Cited by 57
Inflammatory bowel disease and risk of mortality in COPD
Vutcovici, M., Bitton, A., Ernst, P., Kezouh, A., Suissa, S., & Brassard, P. (2016) · European Respiratory Journal · doi:10.1183/13993003.01945-2015 · Cited by 56
Global assessment of the COPD patient: Time to look beyond FEV1?
Papaioannou, A. Ι., Loukides, S., Gourgoulianis, K. I., & Κostikas, Κ. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.01.001 · Cited by 54
Doucet, M., Rochette, L., & Hamel, D. (2016) · Canadian Respiratory Journal · doi:10.1155/2016/7518287 · Cited by 55
Lung cancer and chronic obstructive pulmonary disease: From a clinical perspective
Dai, J., Yang, P., Cox, A., & Jiang, G. (2017) · Oncotarget · doi:10.18632/oncotarget.14505 · Cited by 57
Time for a change: anticipating the diagnosis and treatment of COPD
Agustí, A. G. N., Navarrete, B. A., Cosío, B. G., Echave, J. M., Faner, R., Alonso, J. L. I., Marín, J. M., Soler‐Cataluña, J. J., & Celli, B. R. (2020) · European Respiratory Journal · doi:10.1183/13993003.02104-2020 · Cited by 56
Burke, H., & Wilkinson, T. M. A. (2021) · European Respiratory Review · doi:10.1183/16000617.0041-2021 · Cited by 55
Racial Differences in Waiting List Outcomes in Chronic Obstructive Pulmonary Disease
Lederer, D. J., Benn, E. K. T., Barr, R. G., Wilt, J. S., Reilly, G., Sonett, J. R., Arcasoy, S. M., & Kawut, S. M. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1260oc · Cited by 54
Patient coping strategies in COPD across disease severity and quality of life: a qualitative study
Brien, S., Lewith, G. T., & Thomas, M. D. (2016) · npj Primary Care Respiratory Medicine · doi:10.1038/npjpcrm.2016.51 · Cited by 54
Oroxylin A attenuates cigarette smoke-induced lung inflammation by activating Nrf2
Li, J., Tong, D., Liu, J., Chen, F., & Shen, Y. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.10.011 · Cited by 54
Co-morbidity in Mild-to-Moderate COPD: Comparison to Normal and Restrictive Lung Function
Lindberg, A., Larsson, L.-G., Rönmark, E., & Lundbäck, B. (2011) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2011.629858 · Cited by 53
Chronic Obstructive Pulmonary Disease with Lung Cancer and/or Cardiovascular Disease
Rodriguez‐Roisin, R., & Soriano, J. B. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200807-075th · Cited by 54
Park, Y. B., Rhee, C. K., Yoon, H. K., Oh, Y., Lim, S. Y., Lee, J. H., Yoo, K. H., & Ahn, J. H. (2018) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2018.0029 · Cited by 52
Wang, M., Lin, E. P.-Y., Huang, L., Li, C., Shyr, Y., & Lai, C. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.02.046 · Cited by 51
Matamis, D., Tsagourias, M., Papathanasiou, A. I., Sineffaki, H., Lepida, D., Galiatsou, E., & Nakos, G. (2013) · Journal of Critical Care · doi:10.1016/j.jcrc.2013.11.011 · Cited by 51
Excess Costs of Comorbidities in Chronic Obstructive Pulmonary Disease: A Systematic Review
Huber, M. B., Wacker, M. E., Vogelmeier, C. F., & Leidl, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123292 · Cited by 54
Undas, A., Jankowski, M., Kaczmarek, P., Sładek, K., & Brummel‐Ziedins, K. E. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.05.004 · Cited by 51
Chen, Y., Camp, P. G., Coxson, H. O., ROAD, J. D., Guenette, J. A., Hunt, M. A., & Reid, W. D. (2016) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2016.10.016 · Cited by 54
Lee, H. J., Jhun, B. W., Cho, J., Yoo, K. H., Lee, J. H., Kim, D. K., Lee, J. D., Jung, K., Lee, J. Y., & Park, H. Y. (2017) · International Journal of COPD · doi:10.2147/copd.s145910 · Cited by 51
Wright, D. J., Twigg, M. J., Barton, G., Thornley, T., & Kerr, C. (2014) · International Journal of Pharmacy Practice · doi:10.1111/ijpp.12165 · Cited by 51
Subjects with COPD and productive cough have an increased risk for exacerbations and death
Lindberg, A., Sawalha, S., Hedman, L., Larsson, L.-G., Lundbäck, B., & Rönmark, E. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.12.001 · Cited by 50
Stridsman, C., Skär, L., Hedman, L., Rˆnmark, E., & Lindberg, A. (2014) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2014.922176 · Cited by 50
COPD Exacerbation: Why It Is Important to Avoid ICU Admission
Prediletto, I., Giancotti, G., & Nava, S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12103369 · Cited by 49
Lindberg, A., & Lundbäck, B. (2008) · The Clinical Respiratory Journal · doi:10.1111/j.1752-699x.2008.00086.x · Cited by 49
Calverley, P. M. A., & Scott, S. (2006) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550600977544 · Cited by 50
Erectile dysfunction and sex hormone changes in chronic obstructive pulmonary disease patients
Kahraman, H., Şen, B., Köksal, N., Kılınç, M., & Resim, S. (2013) · Multidisciplinary Respiratory Medicine · doi:10.1186/2049-6958-8-66 · Cited by 49
The Impact of Statin Drug Use on All-Cause Mortality in Patients With COPD
Raymakers, A., Sadatsafavi, M., Sin, D. D., Vera, M. A. D., & Lynd, L. D. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.02.002 · Cited by 48
Future therapeutic treatment of COPD: struggle between oxidants and cytokines.
de Boer, W. I., Yao, H., & Rahman, I. (2007) · PubMed Central · Cited by 49
Cardiovascular Diseases in COPD: From Diagnosis and Prevalence to Therapy
Papaporfyriou, A., Bartziokas, Κ., Gompelmann, D., Idzko, M., Fouka, E., Zaneli, S., Bakakos, P., Loukides, S., & Papaioannou, A. Ι. (2023) · Life · doi:10.3390/life13061299 · Cited by 60
Relation Between COPD Severity and Global Cardiovascular Risk in US Adults
Lee, H. M., Lee, J. S., Lee, K., Luo, Y., Sin, D. D., & Wong, N. D. (2012) · CHEST Journal · doi:10.1378/chest.11-2421 · Cited by 48
Neves, L. F., dos Reis, M. H., & Gonçalves, T. R. (2016) · Cadernos de Saúde Pública · doi:10.1590/0102-311x00085915 · Cited by 48
Park, S. C., Kim, D. W., Park, E., Shin, C. S., Rhee, C. K., Kang, Y. A., & Kim, Y. S. (2019) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2017.428 · Cited by 48
Role of primary care in early diagnosis and effective management of COPD
Bellamy, D., & Smith, J. A. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01447.x · Cited by 48
Varela, M. V. L., de, M. M., Halbert, R. J., Muiño, A., Tálamo, C., Pérez‐Padilla, R., Jardim, J. R., Valdivia, G. G., Pertuzé, J., & Menezes, A. M. B. (2013) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2013.05.003 · Cited by 47
Dreher, M., Doncheva, E., Schwoerer, A., Walterspacher, S., Sonntag, F., Kabitz, H., & Windisch, W. (2008) · Respiration · doi:10.1159/000187717 · Cited by 47
The influence of comorbidities on mortality in sarcoidosis: a observational prospective cohort study
Nowiński, A., Puścińska, E., Goljan, A., Peradzyńska, J., Bednarek, M., Korzybski, D., Kamiński, D., Stokłosa, A., Czystowska, M., Śliwiński, P., et al. (2015) · The Clinical Respiratory Journal · doi:10.1111/crj.12398 · Cited by 46
Kaźmierczak, M., Ciebiada, M., Pękala‐Wojciechowska, A., Pawłowski, M., Nielepkowicz‐Goździńska, A., & Antczak, A. J. (2015) · Heart Lung and Circulation · doi:10.1016/j.hlc.2015.01.019 · Cited by 46
Chubachi, S., Sato, M., Kameyama, N., Tsutsumi, A., Sasaki, M., Tateno, H., Nakamura, H., Asano, K., & Betsuyaku, T. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.07.002 · Cited by 47
Resource Use and Health Care Costs of COPD Patients at the End of Life: A Systematic Review
Faes, K., Frène, V. D., Cohen, J., & Annemans, L. (2016) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2016.04.007 · Cited by 51
Association between lung function, hypertension and blood pressure medication
Schnabel, E., Nowak, D., Brasche, S., Wichmann, H. ‐., & Heinrich, J. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2010.12.023 · Cited by 45
de Voogd, J. N., Wempe, J. B., Postema, K., van Sonderen, E., Ranchor, A. V., Coyne, J. C., & Sanderman, R. (2009) · Annals of Behavioral Medicine · doi:10.1007/s12160-009-9105-8 · Cited by 44
Molecular and clinical diseasome of comorbidities in exacerbated COPD patients
Faner, R., Gutiérrez‐Sacristán, A., Castro-Acosta, A. A., Grosdidier, S., Gan, W., Sánchez, M. T. H., López-Campos, J. L., Pozo-Rodrı́guez, F., Sanz, F., Mannino, D. M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.00763-2015 · Cited by 44
Fumagalli, G., Fabiani, F., Forte, S., Napolitano, M., Marinelli, P., Palange, P., Pentassuglia, A., Carlone, S., & Sanguinetti, C. M. (2013) · Multidisciplinary Respiratory Medicine · doi:10.1186/2049-6958-8-28 · Cited by 44
Determinants of cardiac troponin T elevation in COPD exacerbation – a cross-sectional study
Brekke, P., Omland, T., Holmedal, S. H., Smith, P., & Søyseth, V. (2009) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-9-35 · Cited by 44
Abnormal Levels of Circulating Endothelial Progenitor Cells During Exacerbations of COPD
Sala, E., Villena, C., Balaguer, C., Ríos, Á., Fernández-Palomeque, C., Cosío, B. G., García, J., Noguera, A., & Agustí, A. G. N. (2010) · Lung · doi:10.1007/s00408-009-9225-8 · Cited by 44
Rice, K. L., Schmidt, M. F., Buan, J. S., Lebahn, F., & Schwarzock, T. K. (2011) · Respiratory Care · doi:10.4187/respcare.01059 · Cited by 43
Hanania, N. A. (2008) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2007.12.004 · Cited by 43
Buffels, J., Degryse, J., & Liistro, G. (2008) · Primary Care Respiratory Journal · doi:10.3132/pcrj.2008.00047 · Cited by 42
Fabbri, L. M., Beghé, B., & Agustí, A. G. N. (2011) · Thorax · doi:10.1136/thoraxjnl-2011-200406 · Cited by 42
Banfi, P. I., Cappuccio, A., Latella, M., Reale, L., Muscianisi, E., & Marini, M. G. (2018) · International Journal of COPD · doi:10.2147/copd.s148685 · Cited by 44
Westeinde, S. C. V. ‘., de Koning, H. J., Xu, D., Hoogsteden, H. C., & van Klaveren, R. J. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.01.020 · Cited by 42
Biomarkers in the management of COPD
Lacoma, A., Prat, C., Andreo, F., & Domínguez, J. (2009) · European Respiratory Review · doi:10.1183/09059180.00000609 · Cited by 40
MACE in COPD: addressing cardiopulmonary risk
Hurst, J. R., Gale, C. P., Hurst, J. R., Bhutani, M., Bourbeau, J., Han, M. K., Hawkins, N. M., Lam, C. S. P., Marciniuk, D. D., Price, D. B., et al. (2024) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(24)00038-9 · Cited by 43
Pre-operative pulmonary evaluation of lung cancer patients: a review of the literature
van Tilburg, P. M. B., Stam, H. J., Hoogsteden, H. C., & van Klaveren, R. J. (2009) · European Respiratory Journal · doi:10.1183/09031936.00020508 · Cited by 41
Triplette, M., Justice, A. C., Attia, E. F., Tate, J., Brown, S. T., Goetz, M. B., Kim, J. W., Rodriguez‐Barradas, M. C., Hoo, G. W. S., Wongtrakool, C., et al. (2017) · AIDS · doi:10.1097/qad.0000000000001701 · Cited by 41
Pulmonary Rehabilitation in the Management of Chronic Lung Disease
Cornelison, S. D., & Pascual, R. M. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.12.015 · Cited by 42
Vujić, T., Nagorni, O., Maric, G. D., Popović, L., & Janković, J. (2016) · Europe PMC (PubMed Central) · Cited by 41
Malerba, M., Clini, E. M., Malagola, M., & Avanzi, G. C. (2013) · Expert Review of Hematology · doi:10.1586/17474086.2013.814835 · Cited by 41
Yamasaki, A., Harada, T., Fukushima, T., Hashimoto, K., Takata, M., Kodani, M., Okazaki, R., Takeda, K., Watanabe, M., Kurai, J., et al. (2015) · International Journal of COPD · doi:10.2147/copd.s77491 · Cited by 40
Loi, A. T. L. T., Hoonhorst, S. J. M., Franciosi, L., Bischoff, R., Hoffmann, R. F., Heijink, I. H., van Oosterhout, A. J. M., Boezen, H. M., Timens, W., Postma, D. S., et al. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002178 · Cited by 42
Ashley, C., Burton, D., Sverrisdóttir, Y. B., Sander, M., McKenzie, D. K., & Macefield, V. G. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2009.185348 · Cited by 40
Wood-Baker, R. R., Cochrane, B., & Naughton, M. T. (2009) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2009.02109.x · Cited by 40
BODE Index: A New Tool to Stage and Monitor Progression of Chronic Obstructive Pulmonary Disease
Côté, C., & Celli, B. R. (2009) · Advances in respiratory medicine · doi:10.5603/arm.27821 · Cited by 39
Comorbidity in chronic obstructive pulmonary disease. Related to disease severity?
Echave-Sustaeta, J. M., Casanova, L. C., Cosío, B. G., Soler‐Cataluña, J. J., Luján, R. G., & Ribera, X. (2014) · International Journal of COPD · doi:10.2147/copd.s71849 · Cited by 39
Bhatt, S. P., Dransfield, M., Cockcroft, J., Wang‐Jairaj, J., Midwinter, D., Rubin, D. B., Scott-Wilson, C. A., & Crim, C. C. (2017) · International Journal of COPD · doi:10.2147/copd.s117373 · Cited by 39
Predictors of Mortality in Chronic Obstructive Pulmonary Disease
Côté, C., & Celli, B. R. (2007) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2007.05.002 · Cited by 38
Sekine, Y., Hata, A., Koh, E., & Hiroshima, K. (2014) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-014-0386-x · Cited by 38
Celli, B. R. (2012) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201107-039ms · Cited by 38
Mortality trends in women and men with COPD in Ontario, Canada, 1996–2012
Gershon, A. S., Hwee, J., Victor, J. C., Wilton, A. S., Wu, R. C., Day, A., & To, T. M. (2014) · Thorax · doi:10.1136/thoraxjnl-2014-205956 · Cited by 38
Sheng, X., Murphy, M. J., MacDonald, T. M., Schembri, S., Simpson, W. G., Winter, J., Winter, J. H., & Wei, L. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.12.014 · Cited by 38
Yoon, H. K., Park, Y. B., Rhee, C. K., Lee, J. H., & Oh, Y. (2017) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2017.80.3.230 · Cited by 38
Fan, W., Lee, H., Lee, A., Kieu, C., & Wong, N. D. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.08.001 · Cited by 38
Butler, S. J., Ellerton, L., Gershon, A. S., Goldstein, R. S., & Brooks, D. (2020) · Palliative Medicine · doi:10.1177/0269216320929556 · Cited by 38
Systemic manifestations of chronic obstructive pulmonary disease
Warwick, E., Scourfield, A., & Quint, J. K. (2015) · British Journal of Hospital Medicine · doi:10.12968/hmed.2015.76.6.324 · Cited by 38
Review: Systemic consequences of COPD
Tkáč, J., Man, S. F. P., & Sin, D. D. (2007) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465807082374 · Cited by 40
Clinical factors and comorbidities affecting the cost of hospital-treated COPD
Deniz, S., Şengül, A., Aydemir, Y., Emre, J. Ç., & Özhan, M. H. (2016) · International Journal of COPD · doi:10.2147/copd.s120637 · Cited by 37
Jankowski, M., Undas, A., Kaczmarek, P., & Butenas, S. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2010.11.005 · Cited by 37
Almagro, P., Garcı́a, F. L., Cabrera, F. J., Montero, L., Morchón, D., Díez‐Manglano, J., de la Iglesia, F., Roca, F. B., Fernández‐Ruiz, M., Castiella, J., et al. (2010) · Revista Clínica Española · doi:10.1016/j.rce.2009.12.002 · Cited by 36
Huang, C., Nguyễn, P. A., Kuo, P.-L., Iqbal, U., Hsu, Y.-H. E., & Jian, W. (2013) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2013.05.006 · Cited by 36
“Can Do, Do Do” Quadrants and 6-Year All-Cause Mortality in Patients With COPD
Vaes, A. W., Spruit, M. A., Koolen, N., Antons, J. C., de Man, M., Djamin, R. S., van Hees, H. W. H., & Hul, A. J. V. ‘. (2022) · CHEST Journal · doi:10.1016/j.chest.2021.12.657 · Cited by 37
Arrhythmias as trigger for acute exacerbations of chronic obstructive pulmonary disease
Bhatt, S. P., Nanda, S., & Kintzer, J. S. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2012.04.007 · Cited by 36
Gale, C. P., Hurst, J. R., Hawkins, N. M., Bourbeau, J., Han, M. K., Lam, C. S. P., Marciniuk, D. D., Price, D., Stolz, D., Gluckman, T. J., et al. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf119 · Cited by 40
Microalbuminuria in Chronic Obstructive Pulmonary Disease
Bulcun, E., Ekici, M. S., Ekici, A., & Kisa, U. (2013) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2012.735292 · Cited by 35
Yawn, B. P., & Kaplan, A. G. (2008) · Primary Care Respiratory Journal · doi:10.3132/pcrj.2008.00021 · Cited by 36
Kotlyarov, S. N., & Котлярова, А. А. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136711 · Cited by 35
The Influence of COPD on Mortality and Severity Scoring in Community-Acquired Pneumonia
Snijders, D., van der Eerden, M. M., de Graaff, C., & Boersma, W. G. (2009) · Respiration · doi:10.1159/000213757 · Cited by 35
Yoshida, Y., Kage, H., Murakawa, T., Sato, Y., Ota, S., Fukayama, M., & Nakajima, J. (2015) · Annals of Thoracic and Cardiovascular Surgery · doi:10.5761/atcs.oa.14-00200 · Cited by 35
The effect of airflow limitation on the cause of death in patients with COPD
Alfageme, I., Reyes, N., Merino, M., Reina, Á. C., Gallego, J., de Lima, J. R. P., & Hidalgo, Z. P. (2010) · Chronic Respiratory Disease · doi:10.1177/1479972310368692 · Cited by 35
Larsen, K., Lygren, B., Sjaastad, I., Krobert, K. A., Arnkværn, K., Florholmen, G., Larsen, A.-K. R., Levy, F. O., Taskén, K., Skjønsberg, O. H., et al. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn180 · Cited by 35
COPD and PE: A Clinical Dilemma
Wood, K. (2008) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s1183 · Cited by 34
“Causes of death in asthma, COPD and non-respiratory hospitalized patients: a multicentric study”
de la SEPAR, G. E. D. A. (. D. Á. D. A., Campos, J. G. S., Plaza, V., Soriano, J. B., López, C. C., Almonacid, C., Vazquez-Oliva, R., Serrano, J., Quincoces, A. B., Galo, A. P., et al. (2013) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-13-73 · Cited by 34
Carreiro, A., Santos, J. V. D., & Rodrigues, F. (2013) · Revista Portuguesa de Pneumologia · doi:10.1016/j.rppneu.2012.12.004 · Cited by 36
Managing multimorbidity in primary care in patients with chronic respiratory conditions
Morrison, D., Agur, K., Mercer, S. W., Eiras, A., González-Montalvo, J. I., & Gruffydd‐Jones, K. (2016) · npj Primary Care Respiratory Medicine · doi:10.1038/npjpcrm.2016.43 · Cited by 34
Donner, C. F., Raskin, J. M., ZuWallack, R., Nici, L. L., Ambrosino, N., Balbi, B., Blackstock, F. C., Casaburi, R. H., Dreher, M., Effing, T., et al. (2018) · Respiratory Medicine · doi:10.1016/j.rmed.2018.09.003 · Cited by 39
Epicardial Adipose Tissue in Patients with Chronic Obstructive Pulmonary Disease
Zagaceta, J., Zulueta, J. J., Bastarrika, G., Colina, I., Alcaide, A. B., Campo, A., Celli, B. R., & de-Torres, J. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065593 · Cited by 32
Diastolic Dysfunction and COPD Exacerbation
Abusaid, G. H., Barbagelata, A., Tuero, E. I., Mahmood, A., & Sharma, G. (2009) · Postgraduate Medicine · doi:10.3810/pgm.2009.07.2033 · Cited by 34
Physical activity in patients with COPD: the impact of comorbidities
Mantoani, L. C., Dell’Era, S., MacNee, W., & Rabinovich, R. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1354699 · Cited by 35
Pharmacotherapies in Older Adults with COPD: Challenges and Opportunities
Matera, M. G., Hanania, N. A., Maniscalco, M., & Cazzola, M. (2023) · Drugs & Aging · doi:10.1007/s40266-023-01038-0 · Cited by 40
Comorbidity of Heart Failure and Chronic Obstructive Pulmonary Disease: More than Coincidence
Güder, G., & Rutten, F. H. (2014) · Current Heart Failure Reports · doi:10.1007/s11897-014-0212-x · Cited by 34
Metadata
- Authors
- Sin, D. D., Anthonisen, N. R., Soriano, J. B., & Agusti, A. G.
- Affiliations
- St. Paul's Hospital (CA)
- London School of Hygiene & Tropical Medicine (GB)
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2006-11-30
- Volume
- 28
- Issue
- 6
- Pages
- 1245-1257
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2118228748
- Cited by
- 1,052
- References
- 142
- Citations by year
- 2026: 22 · 2025: 44 · 2024: 43 · 2023: 40 · 2022: 36 · 2021: 60 · 2020: 61 · 2019: 55 · 2018: 61 · 2017: 63 · 2016: 76 · 2015: 61 · 2014: 77 · 2013: 74 · 2012: 51
- FWCI
- 7.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Respiratory Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- AstraZeneca
- GlaxoSmithKline
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- chronic obstructive pulmonary disease, COPD mortality, comorbidities, cardiovascular disease, lung cancer, low-grade inflammation, respiratory failure, FEV1, BODE index, St George's Respiratory Questionnaire, mortality prediction, health assessment
- MeSH terms
- Health Status, Humans, Comorbidity, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
